VBY-825 is an orally available novel reversible cathepsin inhibitor that has high inhibitory potency against cathepsin B, L, S and V, and possesses anti-tumor, anti-inflammatory and analgesic effects[1][2][3].
Molecular Weight:
535.55
Purity:
99.81
CAS Number:
[1310340-58-9]
Formula:
C23H29F4N3O5S
Target:
Cathepsin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
